Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report
of the study results is available, it also can be found here.
X www.clinicaltrials.gov. Once you are on the website, type “NCT02474355”
into the search box and click “Search”.
X http://www.clinicaltrialsregister.eu. Once you are on the website, click “Home and
Search”, then type “2015-001407-31” in the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com. Once you are on the website, type “D5160C00022”
into the search box, and click “Find a Study”.
Full Study Title: Open Label, Multinational, Multicenter, Real-World Treatment Study of Single
Agent AZD9291 for Patients with Advanced/Metastatic Epidermal Growth Factor Receptor
(EGFR) T790M Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) Who Have Received
Prior Therapy with an EGFR Tyrosine Kinase Inhibitor (EGFR-TKI)
AstraZeneca Protocol Number: D5160C00022
National Clinical Trials Number: NCT02474355
EudraCT Number: 2015-001407-31
AstraZeneca AB sponsored this study and has its headquarters at Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important
health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_11_09
12 | Clinical Study Results